Ashish Sharma

3.2k total citations
107 papers, 1.6k citations indexed

About

Ashish Sharma is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Ashish Sharma has authored 107 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Ophthalmology, 38 papers in Radiology, Nuclear Medicine and Imaging and 29 papers in Immunology. Recurrent topics in Ashish Sharma's work include Retinal Diseases and Treatments (47 papers), Retinal and Optic Conditions (23 papers) and Biosimilars and Bioanalytical Methods (23 papers). Ashish Sharma is often cited by papers focused on Retinal Diseases and Treatments (47 papers), Retinal and Optic Conditions (23 papers) and Biosimilars and Bioanalytical Methods (23 papers). Ashish Sharma collaborates with scholars based in United States, India and Israel. Ashish Sharma's co-authors include Baruch D. Kuppermann, Francesco Bandello, Nilesh Kumar, M. Cristina Kenney, Nikulaa Parachuri, Anat Loewenstein, Jay Sheth, Anat Loewenstein, Payam Falatoonzadeh and Neetu Gupta and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Journal of the American Society of Nephrology.

In The Last Decade

Ashish Sharma

98 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashish Sharma United States	22	1.0k	748	355	175	74	107	1.6k
Ângela Carneiro Portugal	26	1.4k 1.4×	1.1k 1.4×	273 0.8×	33 0.2×	42 0.6×	109	1.8k
Ning Dong China	22	432 0.4×	238 0.3×	450 1.3×	166 0.9×	58 0.8×	78	1.2k
Jonghyeon Kim United States	17	666 0.6×	310 0.4×	208 0.6×	141 0.8×	95 1.3×	28	1.4k
Toshihiko Nagasawa Japan	23	328 0.3×	290 0.4×	439 1.2×	138 0.8×	40 0.5×	98	1.4k
Ji Hwan Lee South Korea	16	308 0.3×	193 0.3×	211 0.6×	90 0.5×	49 0.7×	57	1.1k
Hui Song China	17	278 0.3×	286 0.4×	353 1.0×	66 0.4×	122 1.6×	108	1.0k
Monica Maria Pagliara Italy	16	456 0.4×	227 0.3×	217 0.6×	184 1.1×	223 3.0×	52	1.4k
Panpan Ye China	17	385 0.4×	277 0.4×	296 0.8×	28 0.2×	59 0.8×	64	887
Ling Yuan China	15	182 0.2×	147 0.2×	122 0.3×	70 0.4×	22 0.3×	38	558

Countries citing papers authored by Ashish Sharma

Since Specialization

Citations

This map shows the geographic impact of Ashish Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashish Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashish Sharma more than expected).

Fields of papers citing papers by Ashish Sharma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashish Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashish Sharma. The network helps show where Ashish Sharma may publish in the future.

Co-authorship network of co-authors of Ashish Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Ashish Sharma. A scholar is included among the top collaborators of Ashish Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashish Sharma. Ashish Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Ashish & B. D. Kuppermann. (2025). Switching to biosimilars in ophthalmology: promise, pitfalls, and the path forward. Expert Review of Ophthalmology. 21(1). 1–3.

Sharma, Ashish, et al.. (2025). Ranibizumab biosimilar (Oceva) – real-world experience from India (RORE study). Expert Opinion on Biological Therapy. 25(12). 1353–1358.

Sharma, Ashish, et al.. (2025). Clinical Trials of Aflibercept Biosimilars: A Review. Journal of Ocular Pharmacology and Therapeutics. 41(7). 363–369.

Sharma, Ashish, Se Joon Woo, Christopher S. Lee, et al.. (2025). Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally. Eye. 39(6). 1026–1027. 1 indexed citations

Sharma, Ashish, Lihteh Wu, Steven Bloom, et al.. (2024). RWC Update: Removal of a Dislocated Ganciclovir Implant; The Role of Early Vitrectomy for Endophthalmitis; Inherited Retinal Disease. Ophthalmic surgery, lasers & imaging retina. 55(7). 363–366. 1 indexed citations

Savoy, Florian M., et al.. (2024). Empowering Portable Age-Related Macular Degeneration Screening: Evaluation of a Deep Learning Algorithm for a Smartphone Fundus Camera. BMJ Open. 14(9). e081398–e081398. 3 indexed citations

Kaur, Rajwinder, et al.. (2024). Diabetic retinopathy screening using MII Ret Cam assisted smartphone-based fundus imaging. 2. 100068–100068. 1 indexed citations

Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Brolucizumab—early real-world experience: BREW study. Eye. 35(4). 1045–1047. 55 indexed citations

Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Correction: Brolucizumab—early real-world experience: BREW study. Eye. 35(4). 1286–1286. 2 indexed citations

10.

Sheth, Jay, Giridhar Anantharaman, Nilesh Kumar, et al.. (2020). Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum. Eye. 34(9). 1501–1503. 11 indexed citations

11.

Sharma, Ashish, Baruch D. Kuppermann, Francesco Bandello, et al.. (2019). Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study. Eye. 34(6). 1063–1068. 19 indexed citations

12.

Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2019). Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression. Eye. 34(3). 422–423. 9 indexed citations

13.

Sharma, Ashish, Nilesh Kumar, Baruch D. Kuppermann, Francesco Bandello, & Anat Loewenstein. (2019). Faricimab: expanding horizon beyond VEGF. Eye. 34(5). 802–804. 58 indexed citations

14.

Yadav, Mukesh, et al.. (2015). Endovascular treatment of central venous obstruction as a complication of prolonged hemodialysis – Preliminary experience in a tertiary care center. Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging. 25(4). 368–374. 8 indexed citations

15.

Sharma, Ashish, et al.. (2014). Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro. SHILAP Revista de lepidopterología. 3 indexed citations

16.

Sharma, Ashish, Ashkan Pirouzmanesh, Jayaprakash Patil, et al.. (2011). Evaluation of the Toxicity of Triamcinolone Acetonide and Dexamethasone Sodium Phosphate on Human Lens Epithelial Cells (HLE B-3). Journal of Ocular Pharmacology and Therapeutics. 27(3). 265–271. 13 indexed citations

17.

Sharma, Ashish, et al.. (2009). Effects of Dexamethasone on Human Trabecular Meshwork Cells in vitro. Investigative Ophthalmology & Visual Science. 50(13). 4071–4071. 1 indexed citations

18.

Saraf, Shubhini A., et al.. (2008). Advancements in traditional medicinal plants used in epilepsy. Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review. 2(4). 229. 2 indexed citations

19.

Pirouzmanesh, Ashkan, et al.. (2008). Evaluation of in vitro Effects of Triamcinolone Acetonide and Dexamethasone on Human Lens Epithelial Cells. Investigative Ophthalmology & Visual Science. 49(13). 2776–2776. 1 indexed citations

20.

Nichols, Kenneth J., Sharmila Dorbala, E. Gordon DePuey, et al.. (1999). Influence of arrhythmias on gated SPECT myocardial perfusion and function quantification.. PubMed. 40(6). 924–34. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact